# Use of Transcollation Device to Decrease Blood Loss During Hepatic Resections: a Randomized Cohort Study (HEPACOLL)

> **NCT01874639** · PHASE2 · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 140 (estimated)

## Conditions studied

- Hepatectomy

## Interventions

- **DEVICE:** standard bipolar coagulation
- **DEVICE:** Aquamantys® probe for liver hemostasis

## Key facts

- **NCT ID:** NCT01874639
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2016-07-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01874639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01874639, "Use of Transcollation Device to Decrease Blood Loss During Hepatic Resections: a Randomized Cohort Study (HEPACOLL)". Retrieved via AI Analytics 2026-09-23 from https://api.ai-analytics.org/clinical/NCT01874639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*